In our study, 9I men, under 65 years of age, with clinically overt coronary heart disease were compared with 98 healthy men in respect of fasting plasma cholesterol, triglyceride and other lipid moieties, relevant past andfamily history, smoking habits, a ponderal index, blood pressure, and prevalence of corneal arcus, xanthomata, and baldness. Some dietary aspects were also taken into account.The analysis showed that the main discriminators were diastolic blood pressure, arcus, baldness, xanthelasma, a family history of hypertension, past smoking habits, and hyperlipidaemia. Of these factors, diastolic hypertension emerges as much the most important.
SYNOPSISThe antiplasmin which migrates electrophoretically with the alpha2 globulins preponderates in effect over that of the alpha1 migrating antiplasmin. This preponderance persists at physiological pH value in vitro and the significance of this finding is discussed.No evidence has been obtained of the existence of anti-urokinase activity in antiplasmin-free serum fractions.The fibrinolytic activity of the enzyme plasmin is inhibited by two different plasma components which migrate electrophoretically with the alpha, and alpha2 globulins respectively. The alpha, migrating antiplasmin combines relatively slowly and irreversibly with plasmin in a manner which is temperature dependent. The alpha2 migrating antiplasmin produces an immediate, temperature-independent inhibition which is more readily reversible (Norman, 1958(Norman, , 1960. In addition, it has been suggested that antiplasmin activity resides largely in the alpha2 globulin fraction (Jacobbson, 1955).Plasmin neutralization may, therefore, be predominantly due to an antiplasmin fraction which combines in a rapid and reversible manner with plasmin. As this concept is of importance, we have undertaken studies of the antiplasmin and antiurokinase activity of each fraction of normal human serum separated by curtain electrophoresis. In this paper, we report the antiplasmin activity of each such fraction, at the pH of the electrophoretic separation and at the physiological pH value, and the anti-urokinase activity of the fractions at the pH of separation, over a range of urokinase concentrations.It has been found that, in this experimental system, the potency of the alpha2 antiplasmin preponderates over that of the alpha1 antiplasmin at both pH values examined. We consider, therefore, that plasmin neutralization is likely to be predominantly rapid and reversible in the circumstances in which these characteristics are typical of the alpha2 antiplasmin.Received for publication 14 October 1965. MATERIALSThe following were used:-Fibrinogen, human, grade L (bottles of 1 g.), Kabi Pharmaceuticals Ltd., plasminogen, human, grade B (120 casein units/vial), Kabi Pharmaceuticals Ltd; plasmin, human, grade B (28 casein units/ vial), Kabi Pharmaceuticals Ltd.; urokinase reference standard, human (2,400 Ploug units/vial), Leo Laboratories Ltd.; thrombin reagent, bovine (2,500 units/vial), Leo Laboratories Ltd.; veronal buffer pH 7 4, 0-154 M.: sodium diethyl barbiturate 11-745 g., sodium chloride 14-67 g., hydrochloric acid 0-1 N 430 ml., distilled water to 2 litres; and Tris citrate buffer pH 8-6: 0-076 M. Tris 9-21 g./litre, 0 005 M. citric acid 1-05 g./litre. METHODFresh human serum was obtained on three separate occasions from a male subject without evidence of arterial disease or altered fibrinolytic activity and each specimen was individually separated by curtain electrophoresis into 47 fractions using Tris citrate buffer pH 8-6. On each occasion, serum was applied at a rate of 38 ml./day. A potential of 2,100 volts was used for a period of 48 hours on two occasions...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.